Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant

Other Complications of Liver Transplant Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

The primary aim of this study is to assess the effect of hyperoncotic albumin on vascular hemodynamics and oxygen delivery after orthotopic liver transplant. The secondary aim is to try to identify the dominant physiological mechanism so that we will be able to better identify patients that may benefit from the use of albumin (25%) boluses in addition to standard care in patients following liver transplantation.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Other Complications of Liver Transplant

• NCT number: NCT01328132
• Study type: Interventional
• Source: McGill University Health Center
• Contact: Sheldon Magder, MD
• Phone: 514-934-1934
• Email: sheldon.magder@muhc.mcgill.ca
• Status: Not yet recruiting
• Phase: Phase 4
• Start date: March 2011
• Completion date: October 2011